CN104664349A - 一种降血糖的中药保健品 - Google Patents
一种降血糖的中药保健品 Download PDFInfo
- Publication number
- CN104664349A CN104664349A CN201310630205.3A CN201310630205A CN104664349A CN 104664349 A CN104664349 A CN 104664349A CN 201310630205 A CN201310630205 A CN 201310630205A CN 104664349 A CN104664349 A CN 104664349A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- healthcare product
- blood sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 210000004369 blood Anatomy 0.000 title abstract description 14
- 239000008280 blood Substances 0.000 title abstract description 14
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 10
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 230000002218 hypoglycaemic effect Effects 0.000 claims abstract description 10
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 9
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 9
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 9
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 9
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 9
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 9
- 240000008042 Zea mays Species 0.000 claims abstract description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 9
- 235000005822 corn Nutrition 0.000 claims abstract description 9
- 244000241872 Lycium chinense Species 0.000 claims description 15
- 235000015468 Lycium chinense Nutrition 0.000 claims description 15
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 244000302512 Momordica charantia Species 0.000 claims description 8
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims description 8
- 241001251949 Xanthium sibiricum Species 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 4
- 230000000055 hyoplipidemic effect Effects 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 4
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 3
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 230000035922 thirst Effects 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 2
- 244000241838 Lycium barbarum Species 0.000 abstract 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 241001633680 Polygonatum odoratum Species 0.000 abstract 2
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 2
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 abstract 2
- 244000067505 Xanthium strumarium Species 0.000 abstract 2
- 235000006533 astragalus Nutrition 0.000 abstract 2
- 235000021018 plums Nutrition 0.000 abstract 2
- 239000002994 raw material Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 2
- 108010001483 Glycogen Synthase Proteins 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011122 softwood Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000002230 Diabetic coma Diseases 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 102000005765 Proto-Oncogene Proteins c-akt Human genes 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 101000600752 Rattus norvegicus 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 108010016297 plasmin drug combination deoxyribonuclease Proteins 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种降血糖的中药保健品，本发明中包括山药10-15份、黄芪10-20份、赤芍8-15份、葛根10-15份、玉米须8-15份、玉竹8-15份、枸杞子6-10份、苍耳子10-15份、当归6-10份、地骨皮6-10份、苦瓜6-10份、乌梅6-10份。它是由下述重量份中药原料药合制而成：山药12份、黄芪18份、赤芍12份、葛根12份、玉米须10份、玉竹10份、枸杞子8份、苍耳子12份、当归8份、地骨皮8份、苦瓜8份、乌梅8份。本发明利用传统中药和现代制剂技术，涉及到降血糖的中药保健品，利用传统中药和现代制剂技术，清理血管垃圾，有效降低血糖浓度，改善口渴症状，配合降糖药物治疗。
Description
技术领域
本发明涉及一种降血糖的中药保健品。
背景技术
糖尿病(Diabetes Mellitus)是一个复合病因的综合病症，是由于体内胰岛素缺乏或拮抗胰岛素的激素增加，或胰岛素在靶细胞内不能发挥正常生理作用而引起的葡萄糖、蛋白质及脂质代谢紊乱的一种综合征。其特征为血循环中葡萄糖浓度异常升高及尿糖、血糖过高时可出现典型的三多一少症状，即多饮、多尿、多食及体重减轻，且伴有疲乏无力。严重者可发生酮症酸中毒、高渗性糖尿病昏迷，且易合并多种感染。随着病程的延长，其代谢紊乱可导致眼、肾、神经、血管及心脏等组织器官的慢性进行性病变。若得不到及时恰当的治疗，则可发生心脏病变、脑血管病变、肾功能衰竭、双目失明、下肢坏疽等而成为致死致残的主要原因。由于原发性糖尿病的病因至今尚未完全阐明，故至今糖尿病尚无根治措施。
采用饮食治疗、运动疗法、口服降糖药、胰岛素及传统医药治疗，只能控制病情，但目前还不能根治糖尿病。
发明内容
本发明提供一种降血糖的中药保健品，利用传统中药和现代制剂技术，清理血管垃圾，有效降低血糖浓度，改善口渴症状，配合降糖药物治疗。
为此，本发明提供了如下中药：包括山药10-15份、黄芪10-20份、赤芍8-15份、葛根10-15份、玉米须8-15份、玉竹8-15份、枸杞子6-10份、苍耳子10-15份、当归6-10份、地骨皮6-10份、苦瓜6-10份、乌梅6-10份。
上述中药由下述重量份中药原料药合制而成：山药12份、黄芪18份、赤芍12份、葛根12份、玉米须10份、玉竹10份、枸杞子8份、苍耳子12份、当归8份、地骨皮8份、苦瓜8份、乌梅8份。
本发明所选药材及药理如下：
山药：甘、平。健脾胃、益肺肾、补虚嬴。山药含有粘液蛋白，有降低血糖的作用，可用于治疗糖尿病，是糖尿病人的食疗佳品。
黄芪：甘，微温。归肺、脾、肝、肾经。固表敛汗、利水消肿、托疮排脓、通调水道、治疗气虚。黄芪可通过增加糖原合成酶活性、胰岛素受体底物活性、蛋白激酶B和蛋白激酶C活性，使糖原合成酶活性增加而发挥增加胰岛素敏感性、降血糖的作用。
赤芍： 苦，微寒。归肝经。使高脂血兔的血浆总胆固醇（Tch），三酰甘油（TG），低密度脂蛋白胆固醇（LDL- Ch）、极低密度脂蛋白胆固醇（VLDL-Ch）显著降低。
葛根：本品可发表解肌、升阳透疹、解热生津，具有显着的降血糖作用。
玉米须：发酵剂对实验动物糖尿病有明显降血糖作用，且对糖尿性高血压、肾病有改善作用。
玉竹：以0.5g/kg玉竹浸剂给家兔肌肉注射，可使血糖升高。口服玉竹浸膏， 则血糖先升后降，对肾上腺素引起的高血糖有显著的抑制作用， 对葡萄糖、四氧嘧啶引起的大鼠高血糖也有抑制作用。
枸杞子：枸杞提取物可显著而持久降低大鼠血糖，增加糖耐量，且毒性较小。另外，该品还有抗肿瘤、促进造血功能等作用。
苍耳子：所含白色结晶性甙(C31H-48O24S2)1mg/kg，可使正常家兔血糖下降。
当归：味甘；辛；苦；性温，归肝；心；脾经。能明显增高冠心病及脑动脉硬化病人纤维蛋白溶酶活性。
地骨皮：甘、寒。归肺、肾经。凉血退蒸，清泄肺热。浸剂、煎剂、酊剂和注射剂均有明显的降压作用。对家兔有轻度的降血糖作用。并有降低血清总胆固醇含量的作用。
苦瓜：性寒味苦、入心、肺、胃，具有清暑解渴、降血压、血脂、养颜美容、促进新陈代谢等功能。降低血糖作用。正常的以及患四氧嘧啶性糖尿病的家兔灌服苦瓜浆汁后，可使血糖明显降低。
乌梅：酸、涩，平。归肝、脾、肺、大肠经。敛肺，涩肠，生津，安蛔。益气养阴，生津止渴，主治虚热烦咳，多饮，多尿，烦躁失眠等症。
具体实施方式
实施例1：
将葛山药12份、黄芪18份、赤芍12份、葛根12份、玉米须10份、玉竹10份、枸杞子8份、苍耳子12份、当归8份、地骨皮8份、苦瓜8份、乌梅8份，原料药加5倍量的水煎煮1小时，除渣取滤液。
旺火将滤液浓缩至膏状，将适量VE、叶酸、牛黄酸、淀粉、糊精加入至浸膏中制软材，过18目筛制粒，60℃干燥1小时，过16目筛整粒。
将上述颗粒装入袋中并封口即为本保健品的颗粒剂。
服用方法：即冲即饮，每日两次，10日为一疗程，一般服用3个疗程后检验。
实施例2：
提取浓缩：运用回流法将浸泡后的山药12份、黄芪18份、赤芍12份、葛根12份、玉米须10份、玉竹10份、枸杞子8份、苍耳子12份、当归8份、地骨皮8份、苦瓜8份、乌梅8份，在90℃的温度下进行提取，蒸馏水的用量为提取原料药材总重量的10倍，提取时间为2小时，提取次数3次；滤过，合并滤液，滤液浓缩至相对密度为2.10(70℃)的浸膏，收集浸膏，备用。
将适量VE、叶酸、牛黄酸、淀粉、加入浸膏中制软材，过18目筛制粒，60℃干燥1小时，过16目筛整粒。
向上述步骤所得的颗粒中加入适量硬脂酸镁、滑石粉、微晶纤维素，压制成片，包糖衣即可。
服用方法：每日两次，每次4粒。
Claims (3)
1.一种降血糖的中药保健品，其特征在于：本发明中包括山药10-15份、黄芪10-20份、赤芍8-15份、葛根10-15份、玉米须8-15份、玉竹8-15份、枸杞子6-10份、苍耳子10-15份、当归6-10份、地骨皮6-10份、苦瓜6-10份、乌梅6-10份。
2.根据权利要求1所述的具有降血脂功能的保健品，其特征在于：它是由下述重量份中药原料药合制而成：山药12份、黄芪18份、赤芍12份、葛根12份、玉米须10份、玉竹10份、枸杞子8份、苍耳子12份、当归8份、地骨皮8份、苦瓜8份、乌梅8份。
3.根据权利要求1和权利要求2所述，其特征在于：这种具有降血脂功能的保健品的剂型可以为颗粒剂，片剂或胶囊剂等。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310630205.3A CN104664349A (zh) | 2013-12-02 | 2013-12-02 | 一种降血糖的中药保健品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310630205.3A CN104664349A (zh) | 2013-12-02 | 2013-12-02 | 一种降血糖的中药保健品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104664349A true CN104664349A (zh) | 2015-06-03 |
Family
ID=53300354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310630205.3A Withdrawn CN104664349A (zh) | 2013-12-02 | 2013-12-02 | 一种降血糖的中药保健品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104664349A (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105639637A (zh) * | 2016-02-01 | 2016-06-08 | 林爱玉 | 一种具有降血糖功能的保健食品 |
| CN106260108A (zh) * | 2016-08-18 | 2017-01-04 | 贵州石阡佛顶山野生油茶油业有限公司 | 一种中药保健茶油及其制备方法 |
| CN106344796A (zh) * | 2016-09-29 | 2017-01-25 | 许超群 | 一种降血糖百香果含片 |
| CN107125761A (zh) * | 2017-05-03 | 2017-09-05 | 贵阳中医学院 | 葛根提取液、葛根酸奶及其制备方法 |
| CN107259032A (zh) * | 2017-04-28 | 2017-10-20 | 江西康之康中药科技有限公司 | 一种降糖茶及其制备方法 |
| CN107581543A (zh) * | 2017-07-21 | 2018-01-16 | 哈尔滨工业大学 | 一种降血糖复合冲剂 |
| CN110051815A (zh) * | 2019-05-06 | 2019-07-26 | 武汉龙族药号生物医药科技有限公司 | 一种辅助降血糖食丸及其制备方法 |
-
2013
- 2013-12-02 CN CN201310630205.3A patent/CN104664349A/zh not_active Withdrawn
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105639637A (zh) * | 2016-02-01 | 2016-06-08 | 林爱玉 | 一种具有降血糖功能的保健食品 |
| CN106260108A (zh) * | 2016-08-18 | 2017-01-04 | 贵州石阡佛顶山野生油茶油业有限公司 | 一种中药保健茶油及其制备方法 |
| CN106344796A (zh) * | 2016-09-29 | 2017-01-25 | 许超群 | 一种降血糖百香果含片 |
| CN107259032A (zh) * | 2017-04-28 | 2017-10-20 | 江西康之康中药科技有限公司 | 一种降糖茶及其制备方法 |
| CN107125761A (zh) * | 2017-05-03 | 2017-09-05 | 贵阳中医学院 | 葛根提取液、葛根酸奶及其制备方法 |
| CN107581543A (zh) * | 2017-07-21 | 2018-01-16 | 哈尔滨工业大学 | 一种降血糖复合冲剂 |
| CN110051815A (zh) * | 2019-05-06 | 2019-07-26 | 武汉龙族药号生物医药科技有限公司 | 一种辅助降血糖食丸及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104664349A (zh) | 一种降血糖的中药保健品 | |
| CN103750107B (zh) | 一种具有降糖功能的保健品 | |
| CN102150692B (zh) | 一种具有治疗糖尿病功能的饼干及其制备方法 | |
| CN102526478B (zh) | 一种增强免疫力、降血糖功能的保健药物配方 | |
| CN102526479B (zh) | 一种增强免疫力、降血糖功能的保健药物 | |
| CN102113651B (zh) | 一种用于糖尿病人食用的馒头及其制备方法 | |
| CN101156689A (zh) | 一种适用于糖尿病人的功能食品 | |
| CN103211257A (zh) | 一种降血糖苹果醋保健饮料及其制备方法 | |
| CN104082672A (zh) | 一种具有降血糖功效的养生粥及其制作方法 | |
| CN102113534B (zh) | 一种具有治疗糖尿病功能的月饼及其制备方法 | |
| CN103349121B (zh) | 降三高保健茶及其制备方法 | |
| CN101856405B (zh) | 一种治疗2型糖尿病的药物组合物及其制备方法 | |
| CN104666971A (zh) | 一种降血糖的中药 | |
| CN101711840B (zh) | 一种适用于癌症患者的药食两用组合物及其制备方法 | |
| CN105395706A (zh) | 用于糖尿病的保健品 | |
| CN102895567B (zh) | 一种治疗糖尿病及其并发症的中草药 | |
| CN102150844B (zh) | 一种具有治疗糖尿病功能的挂面及其制备方法 | |
| CN101279034B (zh) | 一种内服和外用结合治疗糖尿病的组合中药及制备方法 | |
| CN102113668B (zh) | 一种用于糖尿病人食用的速冻水饺及其制备方法 | |
| CN102125128A (zh) | 一种九味降糖茶 | |
| CN104905364A (zh) | 一种降血糖的饮料及其制备方法 | |
| CN103689558A (zh) | 一种具有多种功能的养生保健食品配方及其制备方法 | |
| CN103393938B (zh) | 一种降血糖的中药组合物 | |
| CN101637214A (zh) | 一种具有防治糖尿病效果的口香糖 | |
| CN105031248A (zh) | 一种含有硒虫草的可辅助降血糖的保健品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C04 | Withdrawal of patent application after publication (patent law 2001) | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150603 |